Wednesday, July 14, 2021 2:41:03 PM
OilPatch,
The tabloids have an audience just like Jerry Springer and WWF. Better to just not be part of the audience if you don’t like their brand of “entertainment”. Years ago I got cut off from making comments to Adam’s blogs and since then have moved away from social media and other blog sites except for this forum. Adam took a big hit responding to a comment I made years ago about Direct and he has never lived that one down. The fact that NWBO is at the finish line is a sticking point with him too because he has never acknowledged the positive evidence all around that the science behind the DCVax platform is sound and that cell therapy is taking off because of the promise seen by clinicians in trials like this L Phase 3. Knowing the agendas of the talking heads helps those who wish to benefit from how they play. Best wishes.
The tabloids have an audience just like Jerry Springer and WWF. Better to just not be part of the audience if you don’t like their brand of “entertainment”. Years ago I got cut off from making comments to Adam’s blogs and since then have moved away from social media and other blog sites except for this forum. Adam took a big hit responding to a comment I made years ago about Direct and he has never lived that one down. The fact that NWBO is at the finish line is a sticking point with him too because he has never acknowledged the positive evidence all around that the science behind the DCVax platform is sound and that cell therapy is taking off because of the promise seen by clinicians in trials like this L Phase 3. Knowing the agendas of the talking heads helps those who wish to benefit from how they play. Best wishes.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
